ArticleBehavior genetics2026
Insights into the Cross-Population Transferability of Polygenic Scores for Substance Use.
Article in Behavior genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Polygenic scores have potential for predicting health outcomes based on genomic data. However, their portability across diverse populations is hindered by the overrepresentation of European ancestries in discovery genome-wide association (GWAS) studies. The current study evaluated the transferability of substance use polygenic scores across European, African, American, and East Asian populations. European-based scores demonstrated reduced predictive accuracy in non-European populations with mean relative accuracies of 36% in American, 22.5% in East Asian, and 3.8% in African ancestries. Beyond discrete genetic ancestry groups, we found that European-based score prediction declined as a function of genetic distance from the European-stratified GWAS. That is, predictive accuracy declines as genetic distance, derived from continuous measures of ancestry, from the discovery GWAS increases. We evaluated the extent to which differences across populations in linkage disequilibrium (LD), allele frequency, and heritability explained the reduction in accuracy. Across phenotypes we found that approximately 56.0% of accuracy decline in American ancestries was explained by LD and allele frequency differences, with differences in LD appearing to be the primary factor. For East Asian ancestries this was 67.1% and was 84.0% in African ancestries. Differences across populations in heritability accounted for only small portions of reduced polygenic score transferability. This suggests that LD and frequency differences explain significant portions of accuracy loss, but substantial reductions persist, suggesting contributions from other factors like causal effect size differences. The current study provides important information on the causes and extent of the polygenic score transferability problem and has important implications for refinement of polygenic scores. Expanding the diversity of GWAS and target samples remains essential for improving accuracy and equity in prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.